Research

UK Cannabis Center seminar focuses on effects of cannabis on driving, cognition

Tom Arkell, Ph.D., is a psychopharmacologist and research fellow in the School of Health Sciences at Swinburne University of Technology in Australia. Photo provided.
Tom Arkell, Ph.D., is a psychopharmacologist and research fellow in the School of Health Sciences at Swinburne University of Technology in Australia. Photo provided.

LEXINGTON, Ky. (Aug. 22, 2024) — The University of Kentucky Cannabis Center is sponsoring a series of seminars featuring national and international experts on cannabis science. This series will give UK students, faculty and the general public the chance to hear cutting-edge cannabinoid science across a wide variety of specialties (medicine, pharmacology, public health, impaired driving science, agriculture, legal and social justice). 

The center, based in the UK College of Medicine’s Center on Drug and Alcohol Research, conducts research on the health effects of cannabis, including its risks and benefits when used to treat certain medical conditions.

The next seminar will highlight the work of Tom Arkell, Ph.D., a psychopharmacologist and research fellow at in the School of Health Sciences at Swinburne University of Technology in Australia.

Arkell’s work focuses on understanding how medicinal cannabis impacts driving performance and cognitive function as well as health outcomes such as quality of life. His research has been published in top-tier journals including Psychopharmacology and The Lancet Psychiatry.

“We are excited to host Dr. Arkell’s seminar presentation. His high-quality research has made great contributions to cannabis science, specifically his work on the effects of cannabinoids on attention and driving ability. This work will help us better understand the risks involved and begin to improve safety,” said Center Director Shanna Babalonis, Ph.D. “This type of high-impact research is central to UK Cannabis Center’s mission to help improve the health and well-being of our communities.”

Arkell will present “Effects of Cannabis on Driving and Cognition: From Healthy Volunteers to Patient Populations.”

The seminar will be held via Zoom 9 a.m. EDT. Anyone is welcome to attend. Register online here.

To receive information on upcoming events, contact the UK Cannabis Center at cannabiscenter@uky.edu.

As the state’s flagship, land-grant institution, the University of Kentucky exists to advance the Commonwealth. We do that by preparing the next generation of leaders — placing students at the heart of everything we do — and transforming the lives of Kentuckians through education, research and creative work, service and health care. We pride ourselves on being a catalyst for breakthroughs and a force for healing, a place where ingenuity unfolds. It's all made possible by our people — visionaries, disruptors and pioneers — who make up 200 academic programs, a $476.5 million research and development enterprise and a world-class medical center, all on one campus.   

In 2022, UK was ranked by Forbes as one of the “Best Employers for New Grads” and named a “Diversity Champion” by INSIGHT into Diversity, a testament to our commitment to advance Kentucky and create a community of belonging for everyone. While our mission looks different in many ways than it did in 1865, the vision of service to our Commonwealth and the world remains the same. We are the University for Kentucky.